@misc{indiciae528fa13818c5,
  title = {Silmitasertib, an FDA-designated orphan CK2 Inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington's disease mouse model},
  author = {Pelzel, R. and Herbst, M. A. and Rozema, N. B. and Solem, M. A. and Gomez-Pastor, R.},
  year = {2025},
  doi = {10.1101/2025.11.19.689275},
  url = {https://www.biorxiv.org/content/10.1101/2025.11.19.689275v1},
  note = {Source identifier: 10.1101/2025.11.19.689275}
}